AZULFIDINE Side Effects

6991850-6 | Pancytopenia
on Sep 07, 2010 Female patient from JAPAN , 72 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia. Azulfidine dosage: 1000 Mg/day. During the same period patient was treated with RHEUMATREX (6 Mg For 2 Days) (View Rheumatrex Review and Rheumatrex Label ), WARFARIN (1.5 Mg/day) (View Warfarin Review and Warfarin Label ), PREDNISOLONE (5 Mg/day) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6985959-0 | Diarrhoea, Liver Disorder, Pruritus, Pyrexia, Skin Disorder
Patient was taking Azulfidine (View Usage). Patient had the following side effects: diarrhoea, liver disorder, pruritus, pyrexia, skin disorder on Sep 03, 2010 from JAPAN Additional patient health information: Female patient , 53 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Azulfidine dosage: 1000 Mg Per Day. During the same period patient was treated with PREDONINE (10mg Per Day) (View Predonine Review and Predonine Label ), SOLETON (240 Mg Per Day) (View Soleton Review and Soleton Label ), FAMOTIDINE (40 Mg Per Day) (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

6984616-4 | Diarrhoea, Enterocolitis, Histiocytosis Haematophagic, Pancytopenia, Pyrexia
Adverse event was reported on Sep 02, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: 500 Mg, 2x/day) was diagnosed with musculoskeletal pain and. Location: JAPAN , 59 years of age, weighting 80.25 lb, After Azulfidine was administered, patient had the following side effects: diarrhoea, enterocolitis, histiocytosis haematophagic, pancytopenia, pyrexia. During the same period patient was treated with PREDONINE (2.5 Mg, 2x/day) (View Predonine Review and Predonine Label ), MEROPEN (0.5 G, Unk) (View Meropen Review and Meropen Label ).

6981259-3 | Liver Disorder
on Sep 02, 2010 Female patient from JAPAN , 42 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder. Azulfidine dosage: .


6980583-8 | Chest X-ray Abnormal, Cough, Hypersensitivity, Interstitial Lung Disease
on Sep 02, 2010 Female patient from JAPAN , 51 years of age, weighting 98.33 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient had the following side effects: chest x-ray abnormal, cough, hypersensitivity, interstitial lung disease. Azulfidine dosage: Unk. During the same period patient was treated with RHEUMATREX (Unk) (View Rheumatrex Review and Rheumatrex Label ), RIMATIL (Unk) (View Rimatil Review and Rimatil Label ), REMICADE (Unk) (View Remicade Review and Remicade Label ). Patient was hospitalized.

6978843-X | Pancytopenia, Stomatitis
Patient was taking Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: pancytopenia, stomatitis on Sep 01, 2010 from JAPAN Additional patient health information: Female patient , 81 years of age, weighting 91.93 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), hyperuricaemia, hypertension, osteoporosis (What is osteoporosis?), pneumocystis jiroveci pneumonia and. Azulfidine dosage: 500 Mg, 2x/day. During the same period patient was treated with RHEUMATREX (2 Mg, Twice Daily, Per Week) (View Rheumatrex Review and Rheumatrex Label ), LOXONIN (60 Mg, 3x/day) (View Loxonin Review and Loxonin Label ), ALOSITOL (100 Mg, 1x/day) (View Alositol Review and Alositol Label ), AMLODIPINE BESYLATE (2.5 Mg, 1x/day) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), PREDONINE (10 Mg, 1x/day) (View Predonine Review and Predonine Label ), ALFAROL (1 Ug, 1x/day) (View Alfarol Review and Alfarol Label ), COTRIM (1 G, 1x/day) (View Cotrim Review and Cotrim Label ). Patient was hospitalized.

6976667-0 | Renal Disorder
Adverse event was reported on Aug 30, 2010 by a Male patient taking Azulfidine (View Usage) (Dosage: Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 74 years of age, Patient experienced the following unwanted or unexpected effects: renal disorder. During the same period patient was treated with HYPEN (Unk) (View Hypen Review and Hypen Label ), PREDONINE (Unk) (View Predonine Review and Predonine Label ).

6971458-9 | Enterocolitis
on Aug 27, 2010 Female patient from JAPAN , 63 years of age, was treated with Azulfidine (View Usage). Patient had the following side effects: enterocolitis. Azulfidine dosage: 500 Mg 2x/day Every Other Day. During the same period patient was treated with MONTELUKAST SODIUM (Unk) (View Montelukast Sodium Review and Montelukast Sodium Label ), SALMETEROL XINAFOATE (Unk) (View Salmeterol Xinafoate Review and Salmeterol Xinafoate Label ), EPINASTINE HYDROCHLORIDE (Unk) (View Epinastine Hydrochloride Review and Epinastine Hydrochloride Label ), ERYTHROCIN LACTOBIONATE (Unk) (View Erythrocin Lactobionate Review and Erythrocin Lactobionate Label ), CLEANAL (Unk) (View Cleanal Review and Cleanal Label ), PANTOSIN (Unk) (View Pantosin Review and Pantosin Label ), MAGNESIUM OXIDE (Unk) (View Magnesium Oxide Review and Magnesium Oxide Label ).

6970988-3 | Affective Disorder, Appetite Disorder, Atrial Fibrillation, Blood Potassium Decreased, Bone Disorder, Depression, Dizziness
on Aug 30, 2010 Female patient from UNITED STATES , weighting 109.0 lb, was diagnosed with colitis ulcerative, atrial fibrillation (What is atrial fibrillation?) and was treated with Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: affective disorder, appetite disorder, atrial fibrillation (What is atrial fibrillation?), blood potassium decreased, bone disorder, depression (What is depression?), dizziness (What is dizziness?). Azulfidine dosage: Unk. During the same period patient was treated with SULFASALAZINE (Unk) (View Sulfasalazine Review and Sulfasalazine Label ), FLAGYL (View Flagyl Review and Flagyl Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), CARDIZEM (Unk) (View Cardizem Review and Cardizem Label ), DIGOXIN (Unk) (View Digoxin Review and Digoxin Label ), AMIODARONE (Unk) (View Amiodarone Review and Amiodarone Label ). Patient was hospitalized.

6965571-X | Liver Disorder
Patient was taking Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder on Aug 27, 2010 from JAPAN Additional patient health information: Female patient , 42 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Azulfidine dosage: .

6964796-7 | Chromaturia
Adverse event was reported on Aug 25, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: 1000 Mg, 4x/day) was diagnosed with colitis ulcerative and. Location: UNITED STATES , weighting 200.0 lb, Patient had the following side effects: chromaturia.

6960474-9 | Pericarditis
on Mar 04, 2010 Male patient from UNITED STATES , 26 years of age, was treated with Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: pericarditis. Azulfidine dosage: . During the same period patient was treated with MESALAMINE (View Mesalamine Review and Mesalamine Label ).

6955648-7 | Oculomucocutaneous Syndrome
on Aug 24, 2010 Male patient from JAPAN , 63 years of age, was diagnosed with myositis (What is myositis?) and was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: oculomucocutaneous syndrome. Azulfidine dosage: 500 Mg, 1x/day. During the same period patient was treated with PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6955627-X | Dehydration, Granulocytopenia, Pneumonia, Pyrexia
Patient was taking Azulfidine (View Usage). Patient had the following side effects: dehydration, granulocytopenia, pneumonia (What is pneumonia?), pyrexia on Aug 20, 2010 from JAPAN Additional patient health information: Male patient , 70 years of age, weighting 120.6 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), hypertension, gastritis and. Azulfidine dosage: 250 Mg, 2x/day. During the same period patient was treated with INDOMETHACIN SODIUM (Unk) (View Indomethacin Sodium Review and Indomethacin Sodium Label ), TRICHLORMETHIAZIDE (2 Mg, 1x/day) (View Trichlormethiazide Review and Trichlormethiazide Label ), BLOPRESS (2 Mg, 1x/day) (View Blopress Review and Blopress Label ), AMLODIPINE BESILATE (2.5 Mg, 1x/day) (View Amlodipine Besilate Review and Amlodipine Besilate Label ), GASTROM (1.5 Mg, 2x/day) (View Gastrom Review and Gastrom Label ). Patient was hospitalized.

6941835-0 | Hepatic Function Abnormal, Rash
Adverse event was reported on Aug 16, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: 1g Per Day) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 84 years of age, After Azulfidine was administered, patient had the following side effects: hepatic function abnormal, rash (What is rash?). During the same period patient was treated with CONIEL (Unk) (View Coniel Review and Coniel Label ), LIVALO (Unk) (View Livalo Review and Livalo Label ), ETHYL ICOSAPENTATE (Unk) (View Ethyl Icosapentate Review and Ethyl Icosapentate Label ), AMOBAN (Unk) (View Amoban Review and Amoban Label ). Patient was hospitalized.

6939324-2 | Blood Test Abnormal, C-reactive Protein Abnormal, Pruritus, Rash, Rheumatoid Arthritis
on Aug 10, 2010 Female patient from JAPAN , 69 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: blood test abnormal, c-reactive protein abnormal, pruritus, rash (What is rash?), rheumatoid arthritis (What is rheumatoid arthritis?). Azulfidine dosage: 500 Mg, 2x/day. During the same period patient was treated with CELECOXIB (100 Mg, 2x/day) (View Celecoxib Review and Celecoxib Label ), MUCOSTA (100 Mg, 2x/day) (View Mucosta Review and Mucosta Label ).

6938983-8 | Myeloid Leukaemia
on Aug 12, 2010 Female patient from UNITED STATES , 50 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Azulfidine (View Usage). Patient had the following side effects: myeloid leukaemia. Azulfidine dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), INFLIXIMAB (View Infliximab Review and Infliximab Label ).

6938371-4 | Pancytopenia, Stomatitis
Patient was taking Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: pancytopenia, stomatitis on Aug 17, 2010 from JAPAN Additional patient health information: Female patient , 81 years of age, weighting 91.93 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), hyperuricaemia, hypertension, osteoporosis (What is osteoporosis?), pneumocystis jiroveci pneumonia and. Azulfidine dosage: 500 Mg, 2x/day. During the same period patient was treated with RHEUMATREX (2 Mg, Twice Daily, Per Week) (View Rheumatrex Review and Rheumatrex Label ), LOXONIN (60 Mg, 3x/day) (View Loxonin Review and Loxonin Label ), ALOSITOL (100 Mg, 1x/day) (View Alositol Review and Alositol Label ), AMLODIPINE BESYLATE (2.5 Mg, 1x/day) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), PREDONINE (10 Mg, 1x/day) (View Predonine Review and Predonine Label ), ALFAROL (1 Ug, 1x/day) (View Alfarol Review and Alfarol Label ), COTRIM (1 G, 1x/day) (View Cotrim Review and Cotrim Label ). Patient was hospitalized.

6938329-5 | Faeces Discoloured
Adverse event was reported on Aug 16, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: 500 Mg, 2x/day) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 56 years of age, weighting 134.5 lb, Patient experienced the following unwanted or unexpected effects: faeces discoloured. During the same period patient was treated with D ALFA (1ug, Unk) (View D Alfa Review and D Alfa Label ), TENORMIN (25mg, Unk) (View Tenormin Review and Tenormin Label ).

6938297-6 | Chest X-ray Abnormal, Cough, Hypersensitivity
on Aug 12, 2010 Female patient from JAPAN , 51 years of age, weighting 98.33 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient had the following side effects: chest x-ray abnormal, cough, hypersensitivity. Azulfidine dosage: Unk. During the same period patient was treated with RHEUMATREX (Unk) (View Rheumatrex Review and Rheumatrex Label ), RIMATIL (Unk) (View Rimatil Review and Rimatil Label ), REMICADE (Unk) (View Remicade Review and Remicade Label ). Patient was hospitalized.

6936297-3 | Renal Disorder
on Aug 18, 2010 Male patient from JAPAN , 74 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: renal disorder. Azulfidine dosage: Unk. During the same period patient was treated with PREDONINE (Unk) (View Predonine Review and Predonine Label ).

6936257-2 | Neutropenia
Patient was taking Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia on Aug 14, 2010 from CHILE Additional patient health information: Female patient , 30 years of age, was diagnosed with colitis ulcerative and. Azulfidine dosage: Unk. Patient was hospitalized.

6933447-X | Enterocolitis
Adverse event was reported on Aug 10, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: 500 Mg 2x/day Every Other Day) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 63 years of age, Patient had the following side effects: enterocolitis. During the same period patient was treated with MONTELUKAST SODIUM (Unk) (View Montelukast Sodium Review and Montelukast Sodium Label ), SALMETEROL XINAFOATE (Unk) (View Salmeterol Xinafoate Review and Salmeterol Xinafoate Label ), EPINASTINE HYDROCHLORIDE (Unk) (View Epinastine Hydrochloride Review and Epinastine Hydrochloride Label ), ERYTHROCIN LACTOBIONATE (Unk) (View Erythrocin Lactobionate Review and Erythrocin Lactobionate Label ), CLEANAL (Unk) (View Cleanal Review and Cleanal Label ), PANTOSIN (Unk) (View Pantosin Review and Pantosin Label ), MAGNESIUM OXIDE (Unk) (View Magnesium Oxide Review and Magnesium Oxide Label ).

6930399-3 | Oedema Peripheral, Tachycardia
on Aug 06, 2010 Female patient from GERMANY , 36 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: oedema peripheral, tachycardia. Azulfidine dosage: 3000 Mg/day, Unk.

6928768-0 | Anaemia Haemolytic Autoimmune
on Aug 05, 2010 Female patient from JAPAN , 63 years of age, was diagnosed with musculoskeletal pain, gastric ulcer, osteoporosis (What is osteoporosis?), hyperlipidaemia and was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia haemolytic autoimmune. Azulfidine dosage: 1 Tablet Daily. During the same period patient was treated with ALLEGRA (2 Tablets Daily) (View Allegra Review and Allegra Label ), ASPIRIN (1 Tablet Daily) (View Aspirin Review and Aspirin Label ), OMEPRAL (1 Tablet Daily) (View Omepral Review and Omepral Label ), ALENDRONATE SODIUM (1 Tablet Daily) (View Alendronate Sodium Review and Alendronate Sodium Label ), FLUVASTATIN (1 Tablet Daily) (View Fluvastatin Review and Fluvastatin Label ). Patient was hospitalized.

6927423-0 | Blood Lactate Dehydrogenase Increased, Hepatic Enzyme Increased, Lymphoma, Lymphoproliferative Disorder
Patient was taking Azulfidine (View Usage). Patient had the following side effects: blood lactate dehydrogenase increased, hepatic enzyme increased, lymphoma (What is lymphoma?), lymphoproliferative disorder on Aug 04, 2010 from JAPAN Additional patient health information: Female patient , 57 years of age, weighting 132.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Azulfidine dosage: 1000 Mg/day. During the same period patient was treated with RHEUMATREX (8 Mg/day Twice Daily On Wednesday And 4 Mg /day Once Daily On Thursday) (View Rheumatrex Review and Rheumatrex Label ), PREDNISOLONE (5 Mg, 2x/day) (View Prednisolone Review and Prednisolone Label ), RIMATIL (100 Mg, 3x/day) (View Rimatil Review and Rimatil Label ), BREDININ (100 Mg Once Daily On Wednesday Once A Week) (View Bredinin Review and Bredinin Label ), REMICADE (200 Mg/day On 26jan2010, 09feb2010, And 09mar2010) (View Remicade Review and Remicade Label ), TAKEPRON (View Takepron Review and Takepron Label ), MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ), LOXONIN (Unk) (View Loxonin Review and Loxonin Label ).

6923111-5 | Liver Disorder
Adverse event was reported on Aug 02, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: 1g Per Day) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 84 years of age, After Azulfidine was administered, patient had the following side effects: liver disorder. During the same period patient was treated with CONIEL (View Coniel Review and Coniel Label ), LIVALO (View Livalo Review and Livalo Label ), ETHYL ICOSAPENTATE (View Ethyl Icosapentate Review and Ethyl Icosapentate Label ), AMOBAN (View Amoban Review and Amoban Label ). Patient was hospitalized.

6923011-0 | Faeces Discoloured
on Aug 02, 2010 Female patient from JAPAN , 56 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: faeces discoloured. Azulfidine dosage: .

6919183-4 | Dehydration, Granulocytopenia, Pneumonia, Pyrexia
on Jul 30, 2010 Male patient from JAPAN , 70 years of age, weighting 120.6 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), hypertension, gastritis and was treated with Azulfidine (View Usage). Patient had the following side effects: dehydration, granulocytopenia, pneumonia (What is pneumonia?), pyrexia. Azulfidine dosage: 250 Mg, 2x/day. During the same period patient was treated with INDOMETHACIN SODIUM (Unk) (View Indomethacin Sodium Review and Indomethacin Sodium Label ), TRICHLORMETHIAZIDE (2 Mg, 1x/day) (View Trichlormethiazide Review and Trichlormethiazide Label ), BLOPRESS (2 Mg, 1x/day) (View Blopress Review and Blopress Label ), AMLODIPINE BESILATE (2.5 Mg, 1x/day) (View Amlodipine Besilate Review and Amlodipine Besilate Label ), GASTROM (1.5 Mg, 2x/day) (View Gastrom Review and Gastrom Label ). Patient was hospitalized.

6910898-0 | Blood Urine, Disseminated Intravascular Coagulation, Gastrointestinal Haemorrhage, Multi-organ Failure, Oedema, Purpura, Renal Impairment
Patient was taking Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: blood urine, disseminated intravascular coagulation, gastrointestinal haemorrhage, multi-organ failure, oedema, purpura, renal impairment on Jul 27, 2010 from JAPAN Additional patient health information: Male patient , 66 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Azulfidine dosage: 250 Mg, 1x/day. During the same period patient was treated with EPADEL (Unk Mg, 2x/day) (View Epadel Review and Epadel Label ), PREDONINE (5 Mg, 1x/day) (View Predonine Review and Predonine Label ), MUCOSTA (100 Mg, 3x/day) (View Mucosta Review and Mucosta Label ), FLOMOX (100 Mg, 3x/day) (View Flomox Review and Flomox Label ), LASIX (20 Mg, 1x/day) (View Lasix Review and Lasix Label ), MECOBALAMIN (1500 Ug, 1x/day) (View Mecobalamin Review and Mecobalamin Label ), NIFLAN (225 Mg, 1x/day) (View Niflan Review and Niflan Label ). Patient was hospitalized.

6900432-3 | Anaemia Haemolytic Autoimmune
Adverse event was reported on Jul 22, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: 1 Tablet Daily) was diagnosed with musculoskeletal pain, gastric ulcer, osteoporosis (What is osteoporosis?), hyperlipidaemia and. Location: JAPAN , 63 years of age, Patient experienced the following unwanted or unexpected effects: anaemia haemolytic autoimmune. During the same period patient was treated with ALLEGRA (2 Tablets Daily) (View Allegra Review and Allegra Label ), ASPIRIN (1 Tablet Daily) (View Aspirin Review and Aspirin Label ), OMEPRAL (1 Tablet Daily) (View Omepral Review and Omepral Label ), ALENDRONATE SODIUM (1 Tablet Daily) (View Alendronate Sodium Review and Alendronate Sodium Label ), FLUVASTATIN (1 Tablet Daily) (View Fluvastatin Review and Fluvastatin Label ). Patient was hospitalized.

6875307-9 | Blood Pressure Increased, Erythema, Headache, Nausea, Oedema, Systemic Lupus Erythematosus
on Jul 14, 2010 Female patient from JAPAN , 58 years of age, weighting 116.8 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), gastric ulcer and was treated with Azulfidine (View Usage). Patient had the following side effects: blood pressure increased, erythema, headache (What is headache?), nausea (What is nausea?), oedema, systemic lupus erythematosus. Azulfidine dosage: 250 Mg, 2x/day. During the same period patient was treated with CLINORIL (100 Mg, 2x/day) (View Clinoril Review and Clinoril Label ), GASTER (20 Mg, 1x/day) (View Gaster Review and Gaster Label ), SELBEX (0.5 G, 2x/day) (View Selbex Review and Selbex Label ). Patient was hospitalized.

6871237-7 | Blood Lactate Dehydrogenase Increased, Hepatic Enzyme Increased, Lymphoma, Lymphoproliferative Disorder
on Jul 13, 2010 Female patient from JAPAN , 57 years of age, weighting 132.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: blood lactate dehydrogenase increased, hepatic enzyme increased, lymphoma (What is lymphoma?), lymphoproliferative disorder. Azulfidine dosage: 1000 Mg/day. During the same period patient was treated with RHEUMATREX (8 Mg/day Twice Daily On Wednesday And 4 Mg /day Once Daily On Thursday) (View Rheumatrex Review and Rheumatrex Label ), PREDNISOLONE (5 Mg, 2x/day) (View Prednisolone Review and Prednisolone Label ), RIMATIL (100 Mg, 3x/day) (View Rimatil Review and Rimatil Label ), BREDININ (100 Mg Once Daily On Wednesday Once A Week) (View Bredinin Review and Bredinin Label ), REMICADE (200 Mg/day On 26jan2010, 09feb2010, And 09mar2010) (View Remicade Review and Remicade Label ), TAKEPRON (View Takepron Review and Takepron Label ), MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ), LOXONIN (Unk) (View Loxonin Review and Loxonin Label ).

6861032-7 | Bronchiolitis
Patient was taking Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: bronchiolitis on Jul 08, 2010 from JAPAN Additional patient health information: Male patient , 42 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Azulfidine dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6856757-3 | Dyspnoea, Interstitial Lung Disease
Adverse event was reported on Jul 07, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 65 years of age, Patient had the following side effects: dyspnoea, interstitial lung disease. During the same period patient was treated with D PENICILLAMINE (View D-penicillamine Review and D-penicillamine Label ). Patient was hospitalized.

6848579-4 | Blood Pressure Increased, Erythema, Headache, Nausea, Oedema, Pyrexia, Systemic Lupus Erythematosus
on Jul 06, 2010 Female patient from JAPAN , 58 years of age, weighting 116.8 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), gastric ulcer and was treated with Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: blood pressure increased, erythema, headache (What is headache?), nausea (What is nausea?), oedema, pyrexia, systemic lupus erythematosus. Azulfidine dosage: 250 Mg, 2x/day. During the same period patient was treated with CLINORIL (100 Mg, 2x/day) (View Clinoril Review and Clinoril Label ), GASTER (20 Mg, 1x/day) (View Gaster Review and Gaster Label ), SELBEX (0.5 G, 2x/day) (View Selbex Review and Selbex Label ). Patient was hospitalized.

6847922-X | Dehydration, Pancytopenia, Pyrexia
on Jul 05, 2010 Male patient from JAPAN , 70 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, pancytopenia, pyrexia. Azulfidine dosage: 500mg Per Day. During the same period patient was treated with ADOAIR (View Adoair Review and Adoair Label ). Patient was hospitalized.

6844978-5 | Angina Pectoris, Immunoglobulins Decreased, Pyrexia
Patient was taking Azulfidine (View Usage). Patient had the following side effects: angina pectoris, immunoglobulins decreased, pyrexia on Jul 02, 2010 from JAPAN Additional patient health information: Male patient , 52 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), gastritis prophylaxis and. Azulfidine dosage: 250 Mg, 2x/day. During the same period patient was treated with MUCOSTA (100 Mg, 2x/day) (View Mucosta Review and Mucosta Label ), NOVORAPID (6 - 10 Units Before Each Meal) (View Novorapid Review and Novorapid Label ), LANTUS (14 Units Before Bed) (View Lantus Review and Lantus Label ), LAMISIL (125 Mg, 1x/day) (View Lamisil Review and Lamisil Label ). Patient was hospitalized.

6840744-5 | Angina Pectoris, Immunoglobulins Decreased, Pyrexia
Adverse event was reported on Jul 02, 2010 by a Male patient taking Azulfidine (View Usage) (Dosage: 250 Mg, 2x/day) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), gastritis prophylaxis and. Location: JAPAN , 52 years of age, After Azulfidine was administered, patient had the following side effects: angina pectoris, immunoglobulins decreased, pyrexia. During the same period patient was treated with MUCOSTA (100 Mg, 2x/day) (View Mucosta Review and Mucosta Label ), NOVORAPID (6 - 10 Units Before Each Meal) (View Novorapid Review and Novorapid Label ), LANTUS (14 Units Before Bed) (View Lantus Review and Lantus Label ), LAMISIL (125 Mg, 1x/day) (View Lamisil Review and Lamisil Label ). Patient was hospitalized.

6835748-2 | Bronchiolitis
on Jun 30, 2010 Male patient from JAPAN , 42 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: bronchiolitis. Azulfidine dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6835724-X | Dyspnoea, Interstitial Lung Disease
on Jun 30, 2010 Female patient from JAPAN , 65 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). Patient had the following side effects: dyspnoea, interstitial lung disease. Azulfidine dosage: . During the same period patient was treated with D PENICILLAMINE (View D-penicillamine Review and D-penicillamine Label ). Patient was hospitalized.

6835677-4 | Hyperparathyroidism Primary, Parathyroid Tumour Benign
Patient was taking Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: hyperparathyroidism primary, parathyroid tumour benign on Jul 01, 2010 from JAPAN Additional patient health information: Male patient , 56 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Azulfidine dosage: 500 Mg, 2x/day. Patient was hospitalized.

6835668-3 | Herpes Zoster, Post Herpetic Neuralgia
Adverse event was reported on Jul 01, 2010 by a Male patient taking Azulfidine (View Usage) (Dosage: 250 Mg, 2x/day) was diagnosed with musculoskeletal pain, inflammation, rheumatoid arthritis (What is rheumatoid arthritis?), gastric ulcer, osteoporosis prophylaxis, tuberculosis (What is tuberculosis?) and. Location: JAPAN , 80 years of age, weighting 134.5 lb, Patient experienced the following unwanted or unexpected effects: herpes zoster, post herpetic neuralgia. During the same period patient was treated with PREDNISOLONE (5 Mg Daily) (View Prednisolone Review and Prednisolone Label ), ETANERCEPT (25 Mg, 2x/week) (View Etanercept Review and Etanercept Label ), CELECOXIB (200 Mg, 2x/day) (View Celecoxib Review and Celecoxib Label ), TAKEPRON (15 Mg, 2x/day) (View Takepron Review and Takepron Label ), ROCALTROL (0.25 Ug, 2x/day) (View Rocaltrol Review and Rocaltrol Label ), ISCOTIN (3 Tablets Per Day) (View Iscotin Review and Iscotin Label ), ALENDRONATE SODIUM (35 Mg, 1x/day) (View Alendronate Sodium Review and Alendronate Sodium Label ). Patient was hospitalized.

6832312-6 | Diarrhoea, Histiocytosis Haematophagic, Pancytopenia, Pyrexia
on Jun 30, 2010 Female patient from JAPAN , 59 years of age, weighting 80.25 lb, was diagnosed with musculoskeletal pain and was treated with Azulfidine (View Usage). Patient had the following side effects: diarrhoea, histiocytosis haematophagic, pancytopenia, pyrexia. Azulfidine dosage: 500 Mg, 2x/day. During the same period patient was treated with PREDONINE (2.5 Mg, 2x/day) (View Predonine Review and Predonine Label ), MEROPEN (0.5 G, Unk) (View Meropen Review and Meropen Label ).

6823509-X | Erythema, Pyrexia, Swelling
on Jun 29, 2010 Female patient from JAPAN , 58 years of age, was treated with Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: erythema, pyrexia, swelling. Azulfidine dosage: Unk. Patient was hospitalized.

6813456-1 | Blood Lactate Dehydrogenase Increased, Hepatic Enzyme Increased, Lymphoma, Lymphoproliferative Disorder
Patient was taking Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactate dehydrogenase increased, hepatic enzyme increased, lymphoma (What is lymphoma?), lymphoproliferative disorder on Jun 25, 2010 from JAPAN Additional patient health information: Female patient , 57 years of age, weighting 132.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Azulfidine dosage: 1000 Mg/day. During the same period patient was treated with RHEUMATREX (8 Mg/day Twice Daily On Wednesday And 4 Mg /day Once Daily On Thursday) (View Rheumatrex Review and Rheumatrex Label ), PREDNISOLONE (5 Mg, 2x/day) (View Prednisolone Review and Prednisolone Label ), RIMATIL (100 Mg, 3x/day) (View Rimatil Review and Rimatil Label ), BREDININ (100 Mg Once Daily On Wednesday Once A Week) (View Bredinin Review and Bredinin Label ), REMICADE (200 Mg/day On 26jan2010, 09feb2010, And 09mar2010) (View Remicade Review and Remicade Label ), TAKEPRON (View Takepron Review and Takepron Label ), MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ), LOXONIN (Unk) (View Loxonin Review and Loxonin Label ).

6810502-6 | Diarrhoea, Histiocytosis Haematophagic, Pancytopenia, Pyrexia
Adverse event was reported on Jun 23, 2010 by a Female patient taking Azulfidine (View Usage) (Dosage: 500 Mg, 2x/day) was diagnosed with musculoskeletal pain and. Location: JAPAN , 59 years of age, weighting 80.25 lb, Patient had the following side effects: diarrhoea, histiocytosis haematophagic, pancytopenia, pyrexia. During the same period patient was treated with PREDONINE (2.5 Mg, 2x/day) (View Predonine Review and Predonine Label ), MEROPEN (0.5 G, Unk) (View Meropen Review and Meropen Label ).

6803764-2 | Chest X-ray Abnormal, Cough, Hypersensitivity
on Jun 17, 2010 Female patient from JAPAN , weighting 98.33 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Azulfidine (View Usage). After Azulfidine was administered, patient had the following side effects: chest x-ray abnormal, cough, hypersensitivity. Azulfidine dosage: . During the same period patient was treated with RHEUMATREX (Unk) (View Rheumatrex Review and Rheumatrex Label ), RIMATIL (View Rimatil Review and Rimatil Label ), REMICADE (Unk) (View Remicade Review and Remicade Label ). Patient was hospitalized.

6803300-0 | Interstitial Lung Disease, Lung Disorder, Respiratory Failure
on Jun 16, 2010 Male patient from JAPAN , 81 years of age, weighting 111.6 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), gastritis, atrial fibrillation (What is atrial fibrillation?), hypertension, cerebral infarction, diabetes mellitus, cardiac failure, dyslipidaemia and was treated with Azulfidine (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, lung disorder, respiratory failure. Azulfidine dosage: 500 Mg, 2x/day. During the same period patient was treated with RIMATIL (100 Mg, 2x/day) (View Rimatil Review and Rimatil Label ), PARIET (10 Mg, 1x/day) (View Pariet Review and Pariet Label ), DIGOSIN (0.125 Mg, 1x/day) (View Digosin Review and Digosin Label ), NU LOTAN (25 Mg, 1x/day) (View Nu Lotan Review and Nu Lotan Label ), ASPIRIN (100 Mg, 1x/day) (View Aspirin Review and Aspirin Label ), AMARYL (1 Mg, 1x/day) (View Amaryl Review and Amaryl Label ), LASIX (10 Mg, 1x/day) (View Lasix Review and Lasix Label ), LIPITOR (10 Mg, 1x/day) (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

6795316-8 | Bone Marrow Failure, Hepatic Function Abnormal, Viral Infection
Patient was taking Azulfidine (View Usage). Patient had the following side effects: bone marrow failure, hepatic function abnormal, viral infection (What is viral infection?) on Jun 15, 2010 from JAPAN Additional patient health information: Female patient , 52 years of age, weighting 99.21 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Azulfidine dosage: 500 Mg, 2x/day. During the same period patient was treated with AMLODIN (Unk) (View Amlodin Review and Amlodin Label ), BLOPRESS (Unk) (View Blopress Review and Blopress Label ). Patient was hospitalized.